Scientists identify severe asthma species, show air pollutant as likely contributor

https://www.eurekalert.org/pub_releases/2021-04/lu-sis041221.php

 

News Release 13-Apr-2021
For the first time, an analysis identifies non-atopic childhood asthma as more than a set of symptoms, but a distinct disease, driven by early exposure to Benzo[a]pyrene from fossil fuel combustion
Lehigh University

 

Asthma afflicts more than 300 million people worldwide. The most severe manifestation, known as non-Th2, or non-atopic childhood asthma, represents the majority of the cases, greater than 85%, particularly in low-income countries, according to Hyunok Choi (https://health.lehigh.edu/faculty/choi-hyunok), an associate professor at the Lehigh University College of Health (https://health.lehigh.edu/). Yet, whether non-Th2 is a distinct disease (or endotype) or simply a unique set of symptoms (or phenotype) remains unknown.

"Non-Th2 asthma is associated with very poor prognosis in children and great, life-long suffering due to the absence of effective therapies," says Choi. "There is an urgent need to better understand its mechanistic origin to enable early diagnosis and to stop the progression of the disease before it becomes severe."

Studies show that nearly 50% of the children whose asthma is poorly controlled are expected to emerge as severe adult cases. Yet, a one-size-fits-all treatment approach, currently the norm for asthma, is ineffective and, says Choi, and partially responsible for asthma's growing economic burden.

"The primary reason for lack of therapeutic and preventive measures is that no etiologic, or causal, driver has ever been identified for the non-Th2 asthma," says Choi.

Now, for the first time, an epidemiological study, led by Choi, has shown that not only is non-Th2 a distinct disease, its likely inducer is early childhood exposure to airborne Benzo[a]pyrene, a byproduct of fossil fuel combustion. Choi and her colleagues are the first to demonstrate air pollution as a driver of the most challenging type of asthma, the severe subtype which is non-responsive to current therapies.


•••••